Complications of diabetes: Renal disease and promotion of self-management

Quality in Health Care

Volumn 9, Issue 4, 2000, Pages 257-263

  Melville, A ^a   Richardson, R ^b   Lister Sharp, D ^b   McIntosh, A ^c  

^a University of York ^*  (United Kingdom)

^b UNIVERSITY OF YORK   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; DIABETES CONTROL; DIABETES MELLITUS; DISEASE COURSE; HEALTH CARE COST; HUMAN; KIDNEY DISEASE; MORTALITY; REVIEW; RISK FACTOR; SELF CARE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; COST OF ILLNESS; DIABETIC NEPHROPATHIES; DIETARY PROTEINS; GREAT BRITAIN; HEALTH CARE COSTS; HUMANS; LIPIDS; SELF CARE; STATE MEDICINE;

EID: 0347938588     PISSN: 09638172     EISSN: None     Source Type: Journal    
DOI: 10.1136/qhc.9.4.257     Document Type: Review

References (114)

1. Complications of diabetes: Renal disease and promotion of self-management
2. Microalbuminuria in non-insulin dependent diabetes: Its prevalence in Indian compared with Europid patients
3. Prevalence and risk factors for micro- and macroalbuminuria in an Italian population-based cohort of NIDDM subjects
4. Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non insulin dependent) diabetic patients
5. Microalbuminuria in diabetes: A population study of the prevalence and an assessment of three screening tests
6. The prevalence of microalbuminuria in diabetes: A study from North India
7. Prevalence of microalbuminuria in older-onset diabetes
8. Prevalence and associated features of albuminuria in Koreans with NIDDM
9. Comparison of the prevalence and associated features of abnormal albumin excretion in insulin-dependent and non-insulin-dependent diabetes
10. Prospective study of microalbuminuria as predictor of mortality in NIDDM
11. A complete screening of urinary albumin concentration in an unselected diabetic out-patient clinic population
12. The natural history and associations of microalbuminuria in type 2 diabetes during the first year after diagnosis
13. Microalbuminuria in a random cohort of recently diagnosed type 2 (non-insulin dependent) diabetic patients living in the greater Munich area
14. Prevalence of proteinuria in non-insulin dependent diabetes
15. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
16. Ten-year incidence of gross proteinuria in people with diabetes
17. Microalbuminuria and coronary heart disease in NIDDM: An incidence study
18. Evolution, risk factors, and prognostic implications of albuminuria in NIDDM
19. Urinary albumin excretion rate and its determinants after 6 years in non-insulin-dependent diabetic patients
20. Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: Prospective, observational study
21. Influence of cigarette-smoking on the progression of clinical diabetic nephropathy in type 2 diabetic patients
22. Persistent albuminuria as an index of diabetic nephropathy in type 2 diabetic patients in Osaka, Japan: Incidence, risk factors, prognosis and causes of death
23. Albuminuria and 24-h ambulatory blood pressure in normoalbuminuric and microalbuminuric NIDDM patients. A longitudinal study
24. Main risk factors for nephropathy in type 2 diabetes mellitus are plasma cholesterol levels, mean blood pressure, and hyperglycemia
25. Systolic blood pressure relates to the rate of progression of albuminuria in NIDDM
26. UK Prospective Diabetes Study 22. Effect of age a diagnosis on diabetic tissue damage during the first 6 years of NIDDM
27. Rate of progression of albuminuria in type II diabetes, five year prospective study from South India
28. Increased incidence of end stage renal failure secondary to diabetes mellitus in Asian ethnic groups in the United Kingdom
29. The need and demand for renal replacement therapy in ethnic minorities in England
30. Familial clustering of diabetic nephropathy in Brazilian type 2 diabetic patients
31. Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus
32. Role of glycemic control and blood pressure in the development and progression of nephropathy in elderly Japanese NIDDM patients
33. A prospective study of clinical and metabolic associates of proteinuria in patients with type 2 diabetes mellitus
34. Albuminuria and poor glycemic control predict mortality in NIDDM
35. Microalbuminuria: A major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients
36. The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus: A systematic overview of the literature
37. Excess mortality and its relation to hypertension and proteinuria in diabetic patients: The World Health Organisation Multinational Study of Vascular Disease in Diabetes
38. Microalbuminuria in NIDDM
39. Screening for slight albuminuria: A comparison of selected commercially available methods
40. Comparison of six commercial techniques in the measurement of microalbuminuria in diabetic patients
41. Which method for quantifying 'microalbuminuria' in diabetics? Comparison of several immunological methods (immunoturbidimeteric assay, immunonephelometric assay, radioimmunoassay and two semi quantitative tests) for measurement of albumin in urine
42. Assessment of the Albuscreen microalbuminuria kit in diabetic outpatients
43. High incidence of false-positive albuminuria results with the Micro-Bumintest
44. Evaluation of a simple method for the screening of microalbuminuria in diabetic patients
45. Performance of 'Micro-Bumintest' tablets for detection of microalbuminuria in Nauruans (West Pacific Ocean)
46. Screening for early diabetic nephropathy: Which sample to detect microalbuminuria?
47. Detection of microalbuminuria. Receiver operating characteristic curve analysis favors albumin-to-creatinine ratio over albumin concentration
48. Microalbuminuria: Invalidity of simple concentration-based screening tests for early nephropathy due to urinary volumes of diabetic patients
49. A new sensitive ELISA test for spot test of urinary albumin
50. Comparison of methods for determination of microalbuminuria in diabetic patients
51. Predictive value of testing random urine sample to detect microalbuminuria in diabetic subjects during outpatient visit
52. Albumin excretion rate, albumin concentration, and albumin/creatinine ratio compared for screening diabetics for slight albuminuria
53. Single-void urine samples can be used to estimate quantitative microalbuminuria
54. Gender and the clinical usefulness of the albumin: Creatinine ratio
55. Performance of a reagent strip device for quantitation of the urine albumin: Creatinine ratio in a point of care setting
56. Clinical evaluation of a test for immediate and quantitative determination of urinary albumin-to-creatinine ratio. A brief report
57. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
58. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy
59. Antiproteinuric effect of blood-pressure-lowering agents: A meta-analysis of comparative trials
60. Long-term effects of anti-hypertensive agents on proteinuria and renal function
61. Effect of antihypertensive therapy on the kidney in patients with diabetes: A meta-regression analysis
62. Therapeutic efficacy of different antihypertensive drugs in human diabetic nephropathy: An updated meta-analysis
63. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39
64. Greater reduction of urinary albumin excretion in hypertensive type II diabetic patients with incipient nephropathy by lisinopril than by nifedipine
65. Effects of benazepril and nicardipine on microalbuminuria in normotensive and hypertensive patients with diabetes
66. Hypertension and non-insulin dependent diabetes
67. Are angiotensin converting enzyme inhibitors useful for normotensive diabetic patients with microalbuminuria?
68. Effect of low-dose ramipril on microalbuminuria in normotensive or mild hypertensive non-insulin-dependent diabetic patients
69. Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria
70. Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus: A randomized, controlled trial
71. Beware of surrogate outcome measures
72. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study
73. Protein restriction in diabetic renal disease
74. Reduction of albumin excretion rate in normotensive microalbuminuric type 2 diabetic patients during long-term simvastatin treatment
75. Can reduction in hypertriglyceridaemia slow progression of microalbuminuria in patients with non-insulin dependent diabetes mellitus?
76. Renal function and insulin sensitivity during simvastatin treatment in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria
77. Cholesterol-lowering therapy may retard the progression of diabetic nephropathy
78. Cholesterol and coronary heart disease: Screening and treatment
79. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: The Steno type 2 randomised study
80. Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40
81. The cost-effectiveness of treating all patients with type 2 diabetes with angiotensin converting enzyme inhibitors
82. British Hypertension Society guidelines for hypertension management
83. Effects of educational interventions in diabetes care: A meta-analysis of findings
84. Studies of educational interventions and outcomes in diabetic adults: A meta-analysis revisited
85. Meta-analysis of diabetes patient education research: Variations in intervention effects across studies
86. Promoting weight loss in type II diabetes
87. Meta-analysis of the effects of educational and psychosocial interventions on management of diabetes mellitus
88. The Diabetes Education Study: A controlled trial of the effects of diabetes patient education
89. DIABEDS: A randomized controlled trial of the effects of physician and/or patient education on diabetes patient outcomes
90. Diabetes intervention study: Multi-intervention trial in newly diagnosed NIDDM
91. A randomised study of the effects of a home diabetes education program
92. One to one teaching with pictures: Flashcard health education for British Asians with diabetes
93. The maintenance of improved metabolic control after intensified diet therapy in recent type 2 diabetes
94. A telephone-delivered intervention for patients with NIDDM. Effect on coronary risk factors
95. Telematic Expert System Diabeto. New tool for diet self-monitoring for diabetic patients
96. Group education for obese patients with type 2 diabetes: Greater success at less cost
97. Evaluation of an audiovisual diabetes education program: Negative results of a randomised trial of patients with non-insulin dependent diabetes
98. Evaluation of a hospital-based education program for patients with diabetes
99. Therapeutic group education in the follow-up of patients with non-insulin treated, non-insulin dependent diabetes mellitus
100. The relative effectiveness of educational and behavioral instruction programs for patients with NIDDM: A randomised trial
101. Behavioral analysis and behavioral strategies to improve self-management of type II diabetes
102. A brief office-based intervention to facilitate diabetes dietary self-management
103. Effects of a brief office-based intervention to facilitate diabetes dietary self-management
104. Long term effects and costs of brief behavioural dietary intervention for patients with diabetes delivered from the medical office
105. Comparison of behavioral interventions for control of type II diabetes
106. Behavior change, weight loss, and physiological improvements in type II diabetic patients
107. Improving self-care among older patients with type II diabetes: The 'Sixty Something...' study
108. Sex differences in weight loss among adults with type ii diabetes mellitus
109. Problem oriented participatory education in the guidance of adults with non-insulin treated type II diabetes mellitus
110. Patient choice in diabetes education curriculum. Nutritional versus standard content for type 2 diabetes